Geode Capital Management’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
Geode Capital Management's AZR Position: Q3 2026 in Review
Geode Capital Management increased its Azora Therapeutics (AZR) stake by 74% in Q3 2026, buying an estimated $39.4K and bringing the position to 21,546 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4096.
Geode Capital Management first reported a position in AZR in Q4 2018 and has held it in 29 quarters since. The position peaked at $412K in Q3 2021. 22 funds tracked by Wall St. Rank hold AZR as of Q3 2026.
- Geode Capital Management held 21,546 shares of Azora Therapeutics worth $86.4K as of Q3 2026.
- Geode Capital Management bought 9,153 Azora Therapeutics shares in Q3 2026, an estimated $39.4K.
- Azora Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4096 holding.
- Geode Capital Management first reported a position in Azora Therapeutics in Q4 2018 and has held it in 29 quarters since.
- Geode Capital Management's Azora Therapeutics position peaked at $412K in Q3 2021.
- 22 funds tracked by Wall St. Rank held Azora Therapeutics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.